Key statistics
As of last trade, Adicet Bio Inc (ACET:NMQ) traded at 1.57, 49.52% above the 52 week low of 1.05 set on Jul 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.50 |
---|---|
High | 1.57 |
Low | 1.50 |
Bid | 1.56 |
Offer | 1.57 |
Previous close | 1.46 |
Average volume | 453.77k |
---|---|
Shares outstanding | 82.40m |
Free float | 81.09m |
P/E (TTM) | -- |
Market cap | 120.31m USD |
EPS (TTM) | -2.53 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 16:04 BST.
More ▼
- ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
- Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Adicet Bio to Participate in Upcoming Investor Conferences
- Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
- Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
More ▼